Name: PCRX Income Statement - Pacira Biosciences Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

PCRX - Pacira Biosciences, Inc.

USD | NASDAQ | Healthcare

PCRX Income Statement - Pacira Biosciences Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	177.4	196.9	179.5	181.1	168.9	187.3	168.6	178.0	167.1	181.2	163.9	169.5	160.3	172.0	167.5	169.4

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	734.9	726.4	701.0	675.0	666.8	541.5	429.6	421.0	337.3	286.6	276.4	249.0	197.7	85.6	39.1	15.7	14.6	15.0
Cost of Revenue	151.9	149.7	170.4	184.7	199.3	140.3	117.3	106.7	86.8	87.9	110.1	71.8	77.4	54.8	32.1	16.7	12.3	12.3
Gross Profit	583.0	576.7	530.5	490.3	467.5	401.3	312.3	314.3	250.4	198.7	166.3	177.2	120.2	30.8	6.9	(1.1)	2.3
Operating Expenses
Research & Development	120.0	117.3	81.6	76.3	84.8	55.5	59.4	72.1	55.7	57.3	45.7	28.7	18.7	21.6	9.9
Operating Income
Operating Income	24.1	19.2	(73.4)	87.7	60.0	89.9	46.4	10.5	15.9	(24.9)	(32.0)	9.5	(5.2)	(53.3)
Non-Operating
Interest Income	17.8	22.7	19.7	11.4	4.5	0.9	4.6	7.4	6.5	4.1	1.3	0.7	0.4	0.3	0.3	0.3
Tax & Net
Income Tax Expense	8.0	9.8	36.5	19.7	(2.6)	14.4	(125.4)	0.3	0.0	0.1	0.1	0.3	0.2	(0.4)	0.0
Per Share
EPS Basic	0.13	0.16	(2.15)	0.91	0.35	0.95	3.41	(0.27)	(0.01)	(1.07)	(1.02)	0.05	(0.39)	(1.93)	-	-
Supplementary Data
EBITDA	115.3	110.2	5.4	163.2	151.5	118.5	66.3	30.1	29.1	(11.1)	(19.1)	20.9	4.9	(47.5)	(43.7)	(34.8)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	28.1	37.8	26.0	28.2	25.3	23.9	19.1	20.3	18.2	19.5	20.8	18.8	17.1	17.5	19.4	26.3	21.6	15.5	11.6	12.6	15.9	15.3	14.7	13.6	15.8	19.7	20.3	17.8	14.4	14.2	14.9	12.2	14.4	10.0	11.8	18.9	16.6	17.1	9.8	9.4
Selling General & Administrative	93.9	101.6	91.8	88.6	86.8	79.6	74.3	68.1	72.0	65.8	67.9	64.9	70.8	64.0	61.3	65.0
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	21.3	50.0	6.9	13.0	21.2	49.9	6.0	4.5	18.4	47.2	4.1	4.7	19.6	59.2	5.8	6.5
Amortization of Intangibles	14.3	14.3	14.3	14.3	14.3	14.3	14.3	14.3	14.3	14.3	14.3	14.3	14.3	14.3	14.3	14.3
Other Operating Expenses	2.3	-	-	-	(6.2)	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	170.5	194.5	173.2	172.6	166.9	162.5	308.1	149.8	153.9	148.1	146.2	129.6	163.4	181.8	146.2	138.2

Operating Income
Operating Income	6.9	2.3	6.4	8.5	2.0	24.7	(139.5)	28.2	13.2	33.2	17.7	39.9	(3.1)	(9.9)	21.3	31.2	17.4	4.2	31.4	34.8	19.4	18.8	17.6	(7.1)	17.1	1.7	2.4	5.3	1.1	12.3	4.0	6.5	(6.9)	8.5	(3.6)	(15.8)	(14.1)	(2.5)	(20.9)	(6.4)

Tax & Net
Income Tax Expense	2.1	(1.1)	4.1	2.9	3.9	9.5	4.6	17.7	4.7	8.9	5.7	12.1	(6.9)	(8.0)	2.8	2.1	0.5	(1.1)	6.6	6.6	2.4	(1.8)	(124.0)	(0.0)	0.4	1.3	0.3	(1.6)	0.3	0.0	(0.1)	0.0	0.0	0.0	0.0	0.0	0.0	(0.0)	0.0	0.1
Net Income From Continuing Ops	2.9	1.6	5.4	(4.8)	4.8	16.0	(143.5)	18.9	9.0	24.9	10.9	25.8	(19.5)	(10.1)	(0.7)	19.9	6.8
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	2.9	1.6	5.4	(4.8)	4.8	16.0	(143.5)	18.9	9.0	24.9	10.9	25.8	(19.5)	(10.1)	(0.7)	19.9	6.8
Net Income Attributable To Parent	2.9	1.6	5.4	(4.8)	4.8	16.0	(143.5)	18.9	9.0	24.9	10.9	25.8	(19.5)	(10.1)	(0.7)	19.9
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	2.9	1.6	5.4	(4.8)	4.8	16.0	(143.5)	18.9	9.0	24.9	10.9	25.8	(19.5)	(10.1)	(0.7)

Per Share
EPS Basic	0.07	-	0.12	(0.11)	0.10	-	(3.11)	0.41	0.19	-	0.23	0.56	(0.43)	-	(0.02)	0.44	0.15	-	0.40	0.43	0.24	-	3.03	(0.17)	0.19	-	(0.15)	0.07	-	-	-	0.06	(0.26)	-	(0.19)	(0.49)	(0.52)	-	(0.59)	(0.21)
EPS Diluted	0.07	-	0.12	(0.11)	0.10	-	(3.11)	0.39	0.19	-	0.23	0.51	(0.43)	-	(0.02)	0.40	0.15	-
Shares Basic	40.5	-	44.0	45.5	46.3	-	46.1	46.2	46.5	-	46.4	46.1	45.9	-	45.8	45.5	44.9	-
Shares Diluted	40.9	-	44.5	45.5	46.5	-	46.1	50.5	52.2	-	52.1	52.1	45.9	-	45.8	52.5	46.4	-

Supplementary Data
EBITDA	28.2	52.3	13.3	21.5	23.2	74.6	(133.5)	32.7	31.6	80.3	21.8	44.6	16.5	49.3	27.1	37.7	37.4	21.2	35.2	37.7	24.3	27.8	20.7	(4.1)	21.9	10.6	6.0	8.8	4.7	16.4	7.5	9.3	(4.2)	12.1	(0.2)	(12.1)	(10.9)	0.8	(17.6)	(3.2)
EBIT	6.9	2.3	6.4	8.5	2.0	24.7	(139.5)	28.2	13.2	33.2	17.7	39.9	(3.1)	(9.9)	21.3	31.2	17.4	4.2	31.4

Non-Operating
Interest Income	1.9	2.3	8.5	5.0	6.9	5.6	5.5	4.7	3.9	3.4	2.8	2.1	3.1	2.8	1.2	0.3	0.3	0.1	0.2	0.2	0.4	0.7	1.0	1.3	1.6	1.7	1.7	1.8	2.2	2.0	1.6	1.5	1.4	1.3	1.1	1.2	0.5	0.4	0.3	0.3
Interest Expense	3.7	3.9	4.3	4.7	4.6	4.7	4.7	3.9	3.3	3.4	3.5	3.9	9.6	11.0	9.9	8.8	10.2	10.4
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(1.9)	(1.8)	3.2	(10.4)	6.7	0.8	0.7	8.3	0.4	0.6	(1.1)	(2.0)	(23.4)	(8.2)	(19.2)	(9.2)	(10.1)
Pre-Tax Income	5.0	0.6	9.5	(1.9)	8.7	25.5	(138.9)	36.6	13.6	33.7	16.6	37.9	(26.5)	(18.1)	2.1	22.0	7.3